IONIS PHARMACEUTICALS INC's ticker is IONS and the CUSIP is 462222100. A total of 334 filers reported holding IONIS PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.71 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $14,292,664 | -66.6% | 315,094 | -69.8% | 0.17% | -66.9% |
| Q2 2023 | $42,750,470 | +137.8% | 1,041,932 | +156.3% | 0.51% | +102.0% |
| Q3 2022 | $17,979,000 | +273.9% | 406,483 | +212.9% | 0.25% | +239.2% |
| Q2 2022 | $4,809,000 | -32.6% | 129,908 | -32.6% | 0.07% | -36.2% |
| Q1 2022 | $7,136,000 | -43.0% | 192,651 | -53.2% | 0.12% | -35.2% |
| Q4 2021 | $12,521,000 | -7.9% | 411,454 | +1.5% | 0.18% | -19.4% |
| Q3 2021 | $13,599,000 | -64.6% | 405,461 | -57.9% | 0.22% | -69.0% |
| Q2 2021 | $38,446,000 | +79.7% | 963,788 | +102.5% | 0.72% | +50.9% |
| Q1 2021 | $21,396,000 | +14.2% | 475,891 | +43.6% | 0.48% | -4.4% |
| Q4 2020 | $18,736,000 | – | 331,377 | – | 0.50% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tweedy, Browne Co LLC | 3,541,136 | $133,749 | 7.12% |
| Bellevue Group AG | 9,743,900 | $368,027,103 | 4.88% |
| M28 Capital Management LP | 126,300 | $4,770,351 | 4.55% |
| Sicart Associates LLC | 246,258 | $9,301,165 | 3.28% |
| Camber Capital Management LP | 1,925,000 | $72,707 | 2.49% |
| Privium Fund Management B.V. | 148,807 | $5,557,941 | 2.11% |
| Deep Track Capital, LP | 1,205,773 | $45,542,046 | 1.91% |
| BVF INC/IL | 1,121,809 | $42,370,726 | 1.79% |
| Orbimed Advisors | 1,993,600 | $75,298,272 | 1.44% |
| Parkman Healthcare Partners LLC | 141,115 | $5,329,914 | 1.42% |